| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |